Conference Highlights: ACR 2019
New research and recommendations were presented at ACR 2019, The American College of...
Read More
Rheumatology
Rheumatoid Arthritis & CVD Risk
Previous research indicates that patients with rheumatoid arthritis (RA) are at increased risk of...
Read More
Coronary Calcium Score May ID CV Risk in Rheumatoid Arthritis
More active inflammation, high ApoB/ApoA1 ratio, and homocysteine tied to coronary calcium risk
Read More
October 2019 Briefing – Rheumatology
Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Common Sites of Bone Erosion in Rheumatoid Arthritis […]
Read More
A Novel Disease Activity Measure for Systemic Lupus Erythematosus
“There is a well-recognized, unmet need for a new disease activity measure for systemic lupus...
Read More
Psoriasis Tied to High BMI, Low Meat Intake in Japanese Study
Meat, fish intake patterns among psoriasis patients in Japan opposite of those in Western countries
Read More
Serum IL-35 Levels Tied to Bone Loss With Rheumatoid Arthritis
Low BMD, high bone metabolism, low vitamin D also seen in postmenopausal rheumatoid arthritis patients
Read More
Conference Highlights: ASBMR 2019
New research and recommendations were presented at ASBMR 2019, the American Society for Bone and...
Read More
Asthma, Allergic Disease, Smoke Exposure, and RA Risk
Asthma and allergies may be associated with increased risk of rheumatoid arthritis (RA), but...
Read More
Patients With Rheumatic Disease Often Have Trouble Accessing Care
Access issues include getting specialty appointments and affording treatment
Read More
Risk for Long-Term Opioid Use Up in Hidradenitis Suppurativa
Odds higher for HS patients with advancing age, ever smoking, history of depression, comorbidity
Read More
Treatment Guidelines Updated for Ankylosing Spondylitis, Axial SpA
TNFi recommended over secukinumab, ixekizumab for AS and nonradiographic axial SpA as first biologic
Read More
Antibiotic Use Tied to Higher Risk for Rheumatoid Arthritis
Findings show a dose- or frequency-dependent association; all antibiotic classes linked to higher odds for RA
Read More
Prurigo Nodularis Associated With Mental Health Disorders
Odds increased for mental health disorders, HIV infection, systemic illnesses
Read More
Recommendations Developed for Management of Lyme Disease
Public comment period for these guidelines has been extended 30 days to Sept. 9, 2019
Read More
Biologic Tx for Psoriasis May Reduce Coronary Inflammation
Findings indicated by perivascular fat attenuation index, as measured by coronary CT angiography
Read More
FDA: Blood Clot, Death Risk Up With Higher Dose of Tofacitinib
Increased risk seen with 10 mg dose of tofacitinib used for treating ulcerative colitis
Read More
Cancer Risks Examined in Rheumatoid Arthritis Patients
Increased incidences found for lymphoma, lung cancer (in male patients), and cervical cancer
Read More
Filgotinib Bests Placebo in Tx of Refractory Rheumatoid Arthritis
Clinical response rate higher among patients with active RA resistant to treatment with biologic agents
Read More
Initial Sustained Remission Common in Rheumatoid Arthritis
Male sex, early RA, treatment-naive, shorter time to remission tied to greater likelihood of remission
Read More